Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 4, 2005, Pages 230-237

  Tsai, Henry K ^a   Manola, Judith ^b   Abner, Anthony ^c   Talcott, James A ^d   D'Amico, Anthony V ^a   Beard, Clair ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

3 Dimensional conformal radiation therapy; Acute toxicity; Neoadjuvant hormone therapy; Prostate carcinoma; Quality of life

Indexed keywords

ANDROGEN;

ACUTE TOXICITY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCUS; MUSCLE CRAMP; PAIN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RECTUM DISEASE; RECTUM HEMORRHAGE; SELF EVALUATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING; URINARY URGENCY;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; COMBINED MODALITY THERAPY; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PAIN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL;

EID: 21844449396     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.02.005     Document Type: Article

References (16)

1. M.V. Pilepich, J.M. Krall, M. al-Sarraf Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma A randomized comparative trial of the Radiation Therapy Oncology Group Urology 45 1995 616 623
2. M.V. Pilepich, K. Winter, M.J. John Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
3. M. Bolla, D. Gonzalez, P. Warde Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300
4. M. Bolla, L. Collette, L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study) A phase III randomised trial Lancet 360 2002 103 106
5. C.A. Lawton, K. Winter, R. Byhardt Radiation Therapy Oncology Group Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31) Int J Radiat Oncol Biol Phys 38 1997 931 939
6. M.V. Pilepich, R. Caplan, R.W. Byhardt Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy Report of Radiation Therapy Oncology Group Protocol 85-31 J Clin Oncol 15 1997 1013 1021
7. C.A. Lawton, K. Winter, K. Murray Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Int J Radiat Oncol Biol Phys 49 2001 937 946
8. A.V. D'Amico, J. Manola, M. Loffredo 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer A randomized controlled trial JAMA 292 2004 821 827
9. D. Watkins-Bruner, C. Scott, C. Lawton RTOG's first quality of life study-RTOG 90-20 A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 33 1995 901 906
10. O.H. Beahrs, D.E. Henson, R.V.P. Hutter American Joint Committee on Cancer Manual for Staging Cancer 4th ed 1992 Lippincott Williams & Wilkins Philadelphia, PA
11. J.A. Clark, J.A. Talcott Symptom indexes to assess outcomes of treatment for early prostate cancer Med Care 39 2001 1118 1130
12. J.D. Forman, R. Kumar, G. Haas Neoadjuvant hormonal downsizing of localized carcinoma of the prostate Effects on the volume of normal tissue irradiation Cancer Invest 13 1995 8 15
13. W. Lilleby, S.D. Fossa, B.H. Knutsen Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation Radiother Oncol 57 2000 195 200
14. W. Lilleby, E. Dale, D.R. Olsen Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose Acta Oncol 42 2003 10 14
15. M.J. Zelefsky, A. Harrison Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer Reducing the potential morbidity of therapy Urology 49 1997 38 45
16. A. Zurlo, L. Collette, G. van Tienhoven Acute toxicity of conventional radiation therapy for high-risk prostate cancer in EORTC trial 22863 Eur Urol 42 2002 125 132